Looking for a pathology second opinion?
Second opinion on cancer diagnosis. Detailed reports prepared by experienced consultant pathologists with the support of AI algorithms.
Read more about us below
Our Service
TwiceView uses artificial intelligence in cancer diagnosis to provide a pathology second opinion. We offer AI-enhanced reports prepared by two experienced consultant pathologist on digital images of patients tissue slides.
Combination of human knowledge and versatility, utilizing augmented capabilities of digital image diagnosis and precision of artificial intelligence algorithms in cancer diagnosis lead to lower risk of errors and well-grounded cancer treatment decisions. It also enables the use of well-targeted therapy.
TwiceView cooperates with leading companies developing innovative and reliable artificial intelligence cancer diagnosis solutions and is supported by Digital Pathology Team with multiple pathologist review.
Fill out the form providing details of your case with the original pathology report.
Send us the image of scanned slide / the slide with tissue sample or ask your doctor to do it.
Your case will be reviewed by two consultant pathologists with the use of AI supported tools.
2
1
3
You will receive a detailed report in form of the file with a second opinion on cancer diagnosis.
4
Our Report
In our sample report, an AI-based tool for estrogen receptor assessment identified 14,294 positive tumour cells and 294 negative tumour cells, thereby guiding an important clinical decision.
TwiceView reports are prepared by experienced and digitally competent consultant pathologists supported by high-end AI-based tools. AI-enhanced software is capable of detecting features that can be omitted by the human eye. Our work is extensively documented with digital images, and includes:
Our analysis demonstrates how these advantages relate to breast core needle biopsy and prostate core needle biopsy reports and shows their potential to empower clinical decisions.
Download detailed descriptions of the TwiceView reports!
Automatic counting and classification of individual cells.
Precise and repeatable calculations crucial for clinical decisions.
Better adherence to reporting guidelines by working in a digital image environment.
Annotations made on digital images for more precise, transparent and understandable pathological assessments.
Extensive digital image documentation of the pathologist’s work in the report for high transparency and better communication with clinicians.
—
—
—
—
—
In our sample report, an AI-based tool for estrogen receptor assessment identified 14,294 positive tumour cells and 294 negative tumour cells, thereby guiding an important clinical decision.
TwiceView reports are prepared by experienced and digitally competent consultant pathologists supported by high-end AI-based tools. AI-enhanced software is capable of detecting features that can be omitted by the human eye. Our work is extensively documented with digital images, and includes:
Our analysis demonstrates how these advantages relate to breast core needle biopsy and prostate core needle biopsy reports and shows their potential to empower clinical decisions.
Download detailed descriptions of the TwiceView reports!
— Automatic counting and classification of individual cells.
— Precise and repeatable calculations crucial for clinical decisions.
— Better adherence to reporting guidelines by working in a digital image environment.
— Annotations made on digital images for more precise, transparent and understandable pathological assessments.
— Extensive digital image documentation of the pathologist’s work in the report for high transparency and better communication with clinicians.
Get a detailed description of the report:
Pricing
TwiceView charges a flat fee of $599 for a consultation of one case.
This price includes two independent opinions from consultant pathologists plus the results of analysis using an artificial intelligence algorithm. A detailed report is sent in the form of a file to the e-mail address provided.
A report is prepared and sent within 48 hours of receiving the files (digital images of patients tissue slides) or tissue slides arrive to TwiceView.
TwiceView does not cover the shipping costs of slides which we receive, but we will pay for their return.
Currently TwiceView second opinion on cancer diagnosis is limited to breast cancer diagnosis and prostate cancer diagnosis.
$599
TwiceView operates as a medical entity registered under Polish law. This means that your personal data and medical records are strictly protected according Polish and EU regulatory requirements (GDPR).
At TwiceView, we take many steps to keep your data safe. We store them in a secured environment with additional security measures such as 2-Factor-Authentication. To protect patients privacy while analysing images we also apply anonimization. We have prepared appropriate procedures and hold regular security trainings for all teammembers.
Our digitally-experienced team supported by state-of-art artificial intelligence algorithms ensures, that each case is checked as thoroughly, as possible, and all therapeutically applicable information is included in the pathology report.
Witold Rezner, MD, PhD
Chief Medical Officer, Consultant Pathologist
Our Team
Agnieszka Radowicz-Chil, MD, PhD
Consultant Pathologist
Mariusz Książek,
MD, PhD
Consultant Pathologist
Adam Gorczyński, MD, PhD
Consultant Pathologist
Krzysztof Mielech
Chief Operating Officer
Małgorzata Witoń, PhD
Project Manager
Olga Komendacka
Project Manager
Karolina Stoga
Branding and Communication
Technology
Karczówkowska 45
25-713 Kielce, Poland
